SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Patrese who wrote (2253)3/31/1998 12:12:00 PM
From: stock bull  Read Replies (1) of 3725
 
Patrese, this is not an attempt to shake out weak shares in preparation for good news. I think the situation is as stated in the press release. I wonder why IMAT changed auditors...do you think the original auditors found something that IMAT did not want to deal with, so they hired new auditors? However, the new auditors also found the problem and they now want to address the issue. What is the problem? Any one's guess. I must admit, I don't like the sound of this problem. If it were a simple problem, with a simple answer, there would be no need for the extension in filing with the SEC. What ever the problem is, I sure hope it doesn't affect earnings or other financial matters that will have a negative impact on the stock's growth...assuming that the stock will ever grow.

Stock Bull
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News